US Patent Issued to WITTGEN BIOTECHNOLOGIES on Nov. 18 for "Analytical device for performing single cell analysis on tumor using artificial intelligence, and method using the same" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,475,975, issued on Nov. 18, was assigned to WITTGEN BIOTECHNOLOGIES INC. (Seoul, South Korea).

"Analytical device for performing single cell analysis on tumor using artificial intelligence, and method using the same" was invented by Minwoo Jung (Seoul, South Korea) and Sangyoun Rhie (Gwangju-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A device and method are disclosed for performing single-cell tumor analysis using artificial intelligence. Single-cell RNA sequencing data is obtained from a tumor sample of a patient, and pre-processed to remove low-quality or redundant data. Cell types are classified based on gene expression, and tumor...